483
Bora Pharmaceuticals Injectables IncBora Pharmaceuticals Injectables Inc – FDA 483, Jul 22, 2011
Record Details
Cangene bioPharma, Inc. in Baltimore, MD, was inspected by the FDA from July 18-22, 2011, and received a Form 483 with four observations. The inspection revealed significant issues related to inadequate equipment cleaning procedures, inappropriate equipment design, failure to follow aseptic processing procedures, and ineffective employee training, indicating a moderate level of non-compliance.
View Company Profile
ID · 638f9e54-29a8-4fbb-8aa8-fd6f3a361675
Other documents for Bora Pharmaceuticals Injectables Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.